Clinical study on the correlation between non-coding RNA and chemotherapy resistance and prognosis in osteosarcoma

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000037280

Enrollment

Unknown

Registered

2020-08-27

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Tumors

Interventions

Observation group:Nil

Eligibility

Sex/Gender

All

Age

6 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosis of osteosarcoma; (2) Consent to the acquisition of tumor tissue and blood samples; (3) Sign the informed consent.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

Measure	Time frame
local recurrence rate;overall survival;Tumor necrosis;	—

Secondary

Measure	Time frame
Tumor Volumne;Enneking staging;Metastases;	—

Countries

China

Contacts

Public ContactJianping Hu

Department of Orthopaedic Surgery, Shanghai Tenth People's Hospital

shzhangchunlin123@163.com+86 13701605475

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026